BIOMAT Database Logo BIOMAT Database Logo

Non-nucleoside reverse transcriptase inhibitors--an overview. 2003

C Bell, and G V Matthews, and M R Nelson
Chelsea and Westminster Hospital, 369 Fulham Rd, London SW10 9NH, UK.

UI MeSH Term Description Entries
D010078 Oxazines Six-membered heterocycles containing an oxygen and a nitrogen.
D003521 Cyclopropanes Three-carbon cycloparaffin cyclopropane (the structural formula (CH2)3) and its derivatives.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000480 Alkynes Hydrocarbons with at least one triple bond in the linear portion, of the general formula Cn-H2n-2. Acetylenic Compounds,Alkyne,Acetylenes
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D015658 HIV Infections Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS). HTLV-III Infections,HTLV-III-LAV Infections,T-Lymphotropic Virus Type III Infections, Human,HIV Coinfection,Coinfection, HIV,Coinfections, HIV,HIV Coinfections,HIV Infection,HTLV III Infections,HTLV III LAV Infections,HTLV-III Infection,HTLV-III-LAV Infection,Infection, HIV,Infection, HTLV-III,Infection, HTLV-III-LAV,Infections, HIV,Infections, HTLV-III,Infections, HTLV-III-LAV,T Lymphotropic Virus Type III Infections, Human
D048588 Benzoxazines OXAZINES with a fused BENZENE ring. Benzoxazine,Benzoxazinoid,Benzoxazinone,Benzoxazinones,Benzoxazinoids
D018894 Reverse Transcriptase Inhibitors Inhibitors of reverse transcriptase (RNA-DIRECTED DNA POLYMERASE), an enzyme that synthesizes DNA on an RNA template. Reverse Transcriptase Inhibitor,Inhibitors, Reverse Transcriptase,Inhibitor, Reverse Transcriptase,Transcriptase Inhibitor, Reverse
D019380 Anti-HIV Agents Agents used to treat AIDS and/or stop the spread of the HIV infection. These do not include drugs used to treat symptoms or opportunistic infections associated with AIDS. AIDS Drug,AIDS Drugs,Anti-AIDS Agents,Anti-AIDS Drug,Anti-HIV Agent,Anti-HIV Drug,Anti-AIDS Drugs,Anti-HIV Drugs,Agent, Anti-HIV,Agents, Anti-AIDS,Agents, Anti-HIV,Anti AIDS Agents,Anti AIDS Drug,Anti AIDS Drugs,Anti HIV Agent,Anti HIV Agents,Anti HIV Drug,Anti HIV Drugs,Drug, AIDS,Drug, Anti-AIDS,Drug, Anti-HIV,Drugs, AIDS,Drugs, Anti-AIDS,Drugs, Anti-HIV
D019829 Nevirapine A potent, non-nucleoside reverse transcriptase inhibitor used in combination with nucleoside analogues for treatment of HIV INFECTIONS and AIDS. BI-RG-587,Nevirapine Hemihydrate,Viramune,BI RG 587,BIRG587,Hemihydrate, Nevirapine

Related Publications

C Bell, and G V Matthews, and M R Nelson
[Non-nucleoside reverse transcriptase inhibitors].
June 2000, Annales de medecine interne,
C Bell, and G V Matthews, and M R Nelson
Non-nucleoside reverse transcriptase inhibitors.
June 1996, BETA : bulletin of experimental treatments for AIDS : a publication of the San Francisco AIDS Foundation,
C Bell, and G V Matthews, and M R Nelson
Non-nucleoside reverse transcriptase inhibitors: a review.
January 2007, International journal of clinical practice,
C Bell, and G V Matthews, and M R Nelson
[Resistance to non-nucleoside reverse transcriptase inhibitors].
February 2001, Enfermedades infecciosas y microbiologia clinica,
C Bell, and G V Matthews, and M R Nelson
New protease inhibitors and non-nucleoside reverse transcriptase inhibitors.
June 2008, Journal of HIV therapy,
C Bell, and G V Matthews, and M R Nelson
Non-nucleoside reverse transcriptase inhibitors: the NNRTI boom.
November 1999, Antiviral chemistry & chemotherapy,
C Bell, and G V Matthews, and M R Nelson
[Non-nucleoside reverse transcriptase inhibitors. First line therapy].
January 2000, MMW Fortschritte der Medizin,
C Bell, and G V Matthews, and M R Nelson
Clinical uses of non-nucleoside reverse transcriptase inhibitors.
January 2000, Reviews in medical virology,
C Bell, and G V Matthews, and M R Nelson
Toxicity of non-nucleoside analogue reverse transcriptase inhibitors.
May 2003, Seminars in liver disease,
C Bell, and G V Matthews, and M R Nelson
[HIV resistance to non-nucleoside reverse transcriptase inhibitors].
August 2006, Virologie (Montrouge, France),
Copied contents to your clipboard!